Pharmacy Program Quarterly Update Changes Effective Jan. 1, 2026 – Part 1
Summary
6, 2025. Blue Cross and Blue Shield of Texas changed its pharmacy drug lists effective Jan. 1, 2026, with some drugs excluded from coverage and others moved to a higher out-of-pocket payment level, and it added new prior authorization programs and dispensing limits. Humira and Stelara coverage changed on most commercial drug lists starting Jan. 1, 2026, and the CivicaScript versions of capecitabine (50 mg and 500 mg) and dalfampridine (10 mg) became the only generic versions covered for members on all Individual & Family Market and commercial-group drug lists, starting Jan. 1, 2026, or upon renewal.
Get alerts when payers change rules like this one
We check BCBS Texas and other payers every day and email you when a change matches your specialty and state.